Focus on the Alzheimer's and Parkinson's Disease Drugs Market: Drug Classification, Future Therapies and Key Players.

LYON, France -- Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical industry is now available to its catalogue.

Alzheimer's and Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease.

www.reportlinker.com/p059672/Alzheimer-Parkinson-Disease.html

This report analyzes the worldwide markets for Alzheimer's and Parkinson's Disease in Millions of US$.

The Major product segments Analyzed are Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, & NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic dopaminergic /do·pa·min·er·gic/ (do?pah-men-er´jik) activated or transmitted by dopamine; pertaining to tissues or organs affected by dopamine.

do·pa·mi·ner·gic
adj. Agents, Dopamine Agonists, & Other PD Drugs (Include COMT Inhibitors COMT inhibitors
Drugs that block catechol-o-methyl transferase, an enzyme that breaks down dopamine. COMT inhibitors include entacapone and tolcapone.

Mentioned in: Parkinson Disease , MOA-B Inhibitors, and Dopamine dopamine (dōp`əmēn), one of the intermediate substances in the biosynthesis of epinephrine and norepinephrine. See catecholamine.

dopamine

One of the catecholamines, widely distributed in the central nervous system. Amplifiers).

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010.

The report profiles 87 companies including many key and niche players worldwide such as Boehringer Ingelheim, Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were Co., Eisai Inc., Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company and one of the world's largest corporations. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States. , Forest Pharmaceuticals, GlaxoSmithKline PLC, H. Lundbeck A/S, Merz Pharmaceuticals GMBH, Novartis AG Novartis AG

Swiss pharmaceutical company. It was formed through the 1996 merger of two Swiss firms: Ciba (see Ciba-Geigy) and Sandoz, a chemical company with interests in pharmaceuticals, nutrition, and agriculture. , Ortho-McNeil Neurologics, Inc., Pfizer Inc., Roche, Shire Pharmaceuticals PLC, and Valeant Pharmaceuticals International Valeant Pharmaceuticals International is a pharmaceutical company with activities spanning the drug discovery pipeline from target identification through clinical trials and commercialization. .

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL URL
in full Uniform Resource Locator

Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. research and reported select online sources.

Table of content

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Outlook

2. Neurodegenerative Diseases neurodegenerative diseases

diseases characterized by neurodegeneration. Lesions are microscopic only but in chronic disease with massive involvement there may be grossly visible atrophy of affected nervous tissue. Market - A Brief Overview

3. Alzheimer's Market Overview

4. Parkinson's Disease Market Overview

5. Disease Overview

6. Drug Classification

7. Future Therapies

8. New Findings

9. Recent Industry Activity

10. Focus on Select Players

11. Global Market Perspective

III. MARKET

1. The United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.

2. Canada

3. Japan

4. Europe

4a. Germany

4b. France

4c. United Kingdom

4d. Italy

4e. Spain

4f. Rest of Europe

5. Rest of World

IV. COMPETITION

1. Acumen Pharmaceuticals Inc. (USA)

2. Amarin Corporation PLC (UK)

3. Amorfix Life Sciences Ltd. (Canada)

4. Apotex, Inc. (Canada)

5. Asterand PLC (UK)

6. Avicena Group, Inc. (USA)

7. Avigen, Inc. (USA)

8. Axonyx, Inc. (USA)

9. Boehringer Ingelheim GmbH (Germany)

10. Brainstorm Cell Therapeutics, Inc. (USA)

11. Bristol-Myers Squibb Company (USA)

12. Britannia Pharmaceuticals Ltd. (UK)

13. CeNeS Pharmaceuticals PLC (England)

14. Cephalon Ceph´a`lon

n. 1. (Zool.) The head. , Inc. (USA)

15. Ceregene, Inc. (USA)

16. CoMentis, Inc. (USA)

17. Comtan (USA)

18. Desitin Arzneimittel GmbH (Germany)

19. Digilab, Inc. (USA)

20. Draxis Health, Inc. (Canada)

21. Eisai Co., Ltd. (Japan)

22. Eli Lilly and Company (USA)

23. Epix Pharmaceuticals (USA)

24. Ester Neurosciences Ltd. (Israel)

25. Evotec AG (Germany)

26. Exelon (USA)

27. F. Hoffmann-La Roche Ltd. (Switzerland)

28. Forest Laboratories, Inc. (USA)

29. Gedeon Richter Ltd. (Hungary)

30. Gerolymatos P. N., SA (Greece)

31. GlaxoSmithKline PLC (UK)

32. H. Lundbeck AS (Denmark)

33. Idera Pharmaceuticals, Inc.(USA)

34. Immuno-Biological Laboratories Co. Ltd. (Japan)

35. Impax Laboratories, Inc. (USA)

36. Intellect Neurosciences Inc. (USA)

37. Intrexon Corporation (USA)

38. Johnson & Johnson (USA)

39. Kyowa Hakko Kogyo Co., Ltd. (Japan)

40. Medtronic, Inc. (USA)

41. Merck KGaA (Germany)

42. Merz Pharmaceuticals GmbH (Germany)

43. Mirapex (USA)

44. Myriad Genetics, Inc. (USA)

45. Neuren Pharmaceuticals Limited (New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. )

46. Neurim Pharmaceuticals Ltd. (Israel)

47. Neurochem, Inc. (Canada)

48. Neurogen Corporation (USA)

49. Neuro-Hitech, Inc. (USA)

50. Neurologix, Inc. (USA)

51. Neuropharma, S.A. (Spain)

52. Neuroptix Corporation (USA)

53. Newron Pharmaceuticals SpA (Italy)

54. Novartis AG (Switzerland)

55. NsGene A/S (Denmark)

56. Nymox Pharmaceutical Corporation (Canada)

57. Orion Corporation (Finland)

58. Ortho-McNeil Neurologics, Inc. (USA)

59. Pfizer, Inc. (USA)

60. Pharmacopeia Drug Discovery Pharmacopeia Drug Discovery Inc is a US based corporation based in Princeton, New Jersey. They claim that they are trying to commercialize technologies to combinational chemistry. External links

The meaning of the word pharmacopeia

, Inc. (USA)

61. Prana Biotechnology Limited (Australia)

62. Ranbaxy Pharmaceuticals, Inc. (USA)

63. ReGen Therapeutics PLC (UK)

64. ReNeuron Ltd. (UK)

65. Samaritan Pharmaceuticals, Inc. (USA)

66. Sanofi-Aventis (France)

67. Schering Espana SA (Spain)

68. Schwarz Pharma AG (Germany)

69. Sciele Pharma, Inc. (USA)

70. Senexis Limited (UK)

71. Shire Pharmaceuticals Group PLC (UK)

72. Siemens Medical Solutions Siemens Medical Solutions (Siemens Med) is a supplier to the healthcare industry, and is headquartered in Erlangen, Germany. Its U.S. division, Siemens Medical Solutions USA, Inc., is a Delaware corporation, with headquarters in Malvern, Pennsylvania. (USA)

73. Somerset Pharmaceuticals, Inc. (USA)

74. Stalevo (USA)

75. Terapia Ranbaxy (Romania)

76. Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Ltd. (Israel)

77. Titan Pharmaceuticals, Inc. (USA)

78. TorreyPines Therapeutics (USA)

79. Transition Therapeutics, Inc. (USA)

80. Tripos, Inc. (USA)

81. Unipharm Ltd. (Israel)

82. Valeant Pharmaceuticals International (USA)

83. Vernalis PLC (UK)

84. Voyager Pharmaceutical Corporation (USA)

85. Wyeth (USA)

86. Zentiva, A.S. (Czech Republic)

87. Zhejiang Yixin Pharmaceutical Company Limited (China)

More market research reports? Go to http://www.reportlinker.com

http://www.reportlinker.com/ci0232/Neurology-market-research.html

http://agribusinessmarket.wordpress.com

COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Sep 27, 2007
Words:	700
Previous Article:	The Worldwide Glass Fibers Industry - Glass Wool Insulation and Textile Glass Fibers.
Next Article:	Major Challenges and Issues Facing the Battery and Fuel Cell Chemicals and Materials Industry.

Related Articles
Ducks loading up for future.(Sports)(Two transfer quarterbacks from Brigham Young walk on to bolster Oregon's practice squads)
Blood vessel growth factor also does housekeeping.(BIOMEDICINE)
Eschew dull extra points, Ducks, and go for two.(Editorials)(Editorial)
New Report Tracks Developments in the Rapidly Evolving Indian Pharmaceutical Industry.
Identify the Limitations of Current Therapy Available to Oesophageal Cancer Patients and the Potential of Future Therapy With This Detailed...
The Future of Biosimilars: Key Opportunities & Emerging Therapies - It is Speculated That the Earliest Introduction of U.S. Biosimilars is Unlikely...
The Future of Biosimilars: Key Opportunities & Emerging Therapies - It Is Speculated That the Earliest Introduction of U.S Biosimilars Is Unlikely To...
Parkinson's Disease - Colloidal Silver or Colloidal Gold
Health Tests and Common Health Tests
Hard Work Is Bad Management - Business, Relationship, Self